{"version":3,"file":"shared-lib.DyIAoVWS.mjs","names":[],"sources":["https:/framerusercontent.com/modules/fB67ObTpKYUWjMsx3S48/1D4cbbHhPflQXalklpZQ/siteMetadata.js"],"sourcesContent":["// Generated by Framer (55d3d16)\nexport default function metadata(params,activeLocale){return{description:\"IC Targets AS is a life-science company dedicated to the development of manganese-based MRI contrast agents and new methods that will improve diagnostic imaging. The main therapeutic areas of our research are cardiology and oncology.\",favicon:\"https://framerusercontent.com/assets/MMGLwsCghwXt9kPwF2mNWSnkB0.svg\",robots:\"max-image-preview:large\",socialImage:\"https://framerusercontent.com/assets/xk1HewC8OcMn78UzQ0s79wasovo.png\",title:\"IC Targets – Opportunities within the original indication\"};}export const metadataVersion=1;\nexport const __FramerMetadata__ = {\"exports\":{\"metadataVersion\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"default\":{\"type\":\"function\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"__FramerMetadata__\":{\"type\":\"variable\"}}}"],"mappings":"oDACA,SAAwB,EAAS,EAAO,EAAa,CAAC,MAAM,CAAC,YAAY,4OAA4O,QAAQ,sEAAsE,OAAO,0BAA0B,YAAY,uEAAuE,MAAM,4DAA4D"}